FRENOLYN

This brand name is authorized in Cyprus, Malta, Romania, Singapore.

Active ingredients

The drug FRENOLYN contains one active pharmaceutical ingredient (API):

1	Budesonide UNII Q3OKS62Q6X - BUDESONIDE
	Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect. At doses clinically equivalent to systemically acting glucocorticosteroids, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers.
	Read more about Budesonide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FRENOLYN Inhalation powder	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R03BA02	Budesonide	R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BA Glucocorticoids
Discover more medicines within R03BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
MT	Medicines Authority	AA032/07401, AA032/07402
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W43881001, W43881002, W43881003, W43881004, W43882001, W43882002, W43882003, W43882004, W43882005, W43882006
SG	Health Sciences Authority	13870P